Medical Oncology: Early Drug Development Program | Subset Medical Oncology Faculty
From 1995-2007, I was clinical director of the Early Drug Development Center at DF/HCC. I have been director of EDDP at Yale since 2012
Extensive Research Description
Dr. Eder 's particular areas of past and present involvement have been in early clinical trials for cancer/Phase I trials and include high dose chemotherapy, the modulation/ reversal of drug resistance, growth factors, vaccines, immune-oncology, signal transduction pathway inhibitors, cell cycle inhibitors, and molecularly targeted therapies/Precision Medicine.
New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs.
New strategies in personalized medicine for solid tumors: molecular markers and clinical trial designs. Jürgensmeier JM, Eder JP, Herbst RS. Clin Cancer Res. 2014 Sep 1;20(17):4425-35. doi: 10.1158/1078-0432.CCR-13-0753.